Aduro Biotech Appoints Liana Wu as Vice President of Commercial BERKELEY, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced that Liana Wu has joined the company as vice president, commercial. Ms. Wu, a commercial leader...

Aduro Biotech Announces ASCO Presentation of Encouraging Data From Ongoing Phase 1b Clinical Trial of Its Immunotherapy for the Treatment of Mesothelioma BERKELEY, Calif., June 1, 2015 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq:ADRO) today announced the presentation of interim safety and efficacy data from an ongoing Phase 1b clinical trial of its...

Aduro Biotech Announces First Quarter 2015 Financial Results Established major $750M collaboration with Novartis for STING in oncology Strengthened cash position with $200M upfront payment from Novartis and $149.3M in net proceeds from IPO and...